| __timestamp | BeiGene, Ltd. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 6930000 | 5078000000 |
| Thursday, January 1, 2015 | 7311000 | 4717000000 |
| Friday, January 1, 2016 | 20097000 | 5096000000 |
| Sunday, January 1, 2017 | 62602000 | 4986000000 |
| Monday, January 1, 2018 | 195385000 | 4214000000 |
| Tuesday, January 1, 2019 | 388249000 | 3806000000 |
| Wednesday, January 1, 2020 | 600176000 | 3671000000 |
| Friday, January 1, 2021 | 990123000 | 3528000000 |
| Saturday, January 1, 2022 | 1277852000 | 3445000000 |
| Sunday, January 1, 2023 | 1504501000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Data in motion
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Teva Pharmaceutical Industries Limited and BeiGene, Ltd. have taken different paths in this regard over the past decade. From 2014 to 2023, Teva's SG&A expenses have consistently been higher, peaking at approximately $5 billion in 2016. In contrast, BeiGene's expenses have shown a dramatic increase, rising from a modest $7 million in 2014 to $1.5 billion in 2023, reflecting its rapid expansion and growth strategy.
While Teva's expenses have decreased by about 32% from their peak, BeiGene's have surged by over 21,000%, highlighting its aggressive market penetration. This comparison underscores the strategic choices each company has made in managing operational costs, with Teva focusing on cost reduction and BeiGene on scaling operations.
Eli Lilly and Company and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Sanofi vs BeiGene, Ltd.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs TG Therapeutics, Inc.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Teva Pharmaceutical Industries Limited vs Veracyte, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited and Geron Corporation: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Bio-Techne Corporation
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and TG Therapeutics, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Amneal Pharmaceuticals, Inc.
BeiGene, Ltd. or ImmunityBio, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Evotec SE